BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 29882766)

  • 1. Proposed Molecular and miRNA Classification of Gastric Cancer.
    Alessandrini L; Manchi M; De Re V; Dolcetti R; Canzonieri V
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations in gastric cancer with special reference to the early-onset subtype.
    Skierucha M; Milne AN; Offerhaus GJ; Polkowski WP; Maciejewski R; Sitarz R
    World J Gastroenterol; 2016 Feb; 22(8):2460-74. PubMed ID: 26937134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular classification of gastric cancer.
    Chia NY; Tan P
    Ann Oncol; 2016 May; 27(5):763-9. PubMed ID: 26861606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison and applicability of molecular classifications for gastric cancer.
    Serra O; Galán M; Ginesta MM; Calvo M; Sala N; Salazar R
    Cancer Treat Rev; 2019 Jul; 77():29-34. PubMed ID: 31195213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of recent molecular landscape knowledge of gastric cancer.
    Shimizu D; Kanda M; Kodera Y
    Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
    Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
    Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
    World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer.
    Cheng J; Zhuo H; Xu M; Wang L; Xu H; Peng J; Hou J; Lin L; Cai J
    J Transl Med; 2018 Aug; 16(1):216. PubMed ID: 30068360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as promising biomarkers for gastric cancer.
    Wang F; Sun GP; Zou YF; Hao JQ; Zhong F; Ren WJ
    Cancer Biomark; 2012; 11(6):259-67. PubMed ID: 23248184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of microRNA expression profiling studies in human gastric cancer.
    Shrestha S; Hsu SD; Huang WY; Huang HY; Chen W; Weng SL; Huang HD
    Cancer Med; 2014 Aug; 3(4):878-88. PubMed ID: 24902858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer.
    Wisnieski F; Santos LC; Calcagno DQ; Geraldis JC; Gigek CO; Anauate AC; Chen ES; Rasmussen LT; Payão SLM; Artigiani R; Demachki S; Assumpção PP; Lourenço LG; Arasaki CH; Pabinger S; Krainer J; Leal MF; Burbano RR; Arruda Cardoso Smith M
    J Mol Med (Berl); 2020 May; 98(5):707-717. PubMed ID: 32285140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer.
    Liu Y; Zhang X; Zhang Y; Hu Z; Yang D; Wang C; Guo M; Cai Q
    Cancer Lett; 2015 Dec; 369(1):58-66. PubMed ID: 26276722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into roles of the miR-1, -133 and -206 family in gastric cancer (Review).
    Xie M; Dart DA; Owen S; Wen X; Ji J; Jiang W
    Oncol Rep; 2016 Sep; 36(3):1191-8. PubMed ID: 27349337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal Instability in Gastric Cancer Biology.
    Maleki SS; Röcken C
    Neoplasia; 2017 May; 19(5):412-420. PubMed ID: 28431273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenetic mechanisms in gastric cancer.
    Shi J; Qu YP; Hou P
    World J Gastroenterol; 2014 Oct; 20(38):13804-19. PubMed ID: 25320518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actionable gene-based classification toward precision medicine in gastric cancer.
    Ichikawa H; Nagahashi M; Shimada Y; Hanyu T; Ishikawa T; Kameyama H; Kobayashi T; Sakata J; Yabusaki H; Nakagawa S; Sato N; Hirata Y; Kitagawa Y; Tanahashi T; Yoshida K; Nakanishi R; Oki E; Vuzman D; Lyle S; Takabe K; Ling Y; Okuda S; Akazawa K; Wakai T
    Genome Med; 2017 Oct; 9(1):93. PubMed ID: 29089060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.